Two new mixed-ligand Cu(II) coordination polymers: Synthesis, crystal structures and nanosizing for inhibiting spinal tumor activity evaluation

被引:3
作者
Xing, Shuai [1 ]
Yang, Yong [1 ]
Wang, Yong-Gang [1 ]
Ma, Bing [1 ]
Kang, Xue-Wen [1 ]
机构
[1] Lanzhou Univ, Hosp 2, Dept Orthoped, Lanzhou, Gansu, Peoples R China
关键词
Coordination polymer; Cu(II)-complexes; nanostructures; anticancer activity; HYDROTHERMAL SYNTHESIS; COPPER-COMPLEXES; ANTICANCER; TRIAZOLATE; FRAMEWORKS; PROGRAM;
D O I
10.3233/MGC-180757
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
By reaction of 1,2,4-triazole (Htrz) and 1,3,5-benzenetricarboxylic acid (H(3)btc) ligands with copper salts under hydrothermal or solvothermal conditions, two new mixed-lig and Cu(II)-coordination polymers [Cu-5(btc)(2)(ipa)(2)(trz)(2)4(H2O4] (H2O)(2)) (1, H(2)ipa = isophthalic acid) and {[Cu-5(mu(3)-OH)(2)(trz)(2)(btc)(2)(DMF)(2)]} (2, DMF = N,N-dimethylformamide) with interesting structural diversity have been successfully prepared. The structures of compounds 1 and 2 have been fully analyzed via the powder X-ray diffraction (PXRD) measurements, elemental analyses and X-ray single crystal diffraction technology. With the aid of a reflux treatment, both polymers 1 and 2 could be prepared in nanoscale region. Moreover, we studied the anticancer activity of the two nanostructures on three human spinal tumor cells (OPM-2, MM1S and RPMI-8226) via the standard MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay.
引用
收藏
页码:263 / 271
页数:9
相关论文
共 22 条
  • [1] Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
    Berruti, A
    Terzolo, M
    Sperone, P
    Pia, A
    Della Casa, S
    Gross, DJ
    Carnaghi, C
    Casali, P
    Porpiglia, F
    Mantero, F
    Reimondo, G
    Angeli, A
    Dogliotti, L
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (03) : 657 - 666
  • [2] Nanocluster analysis of intermetallic structures with the program package TOPOS
    Blatov, V. A.
    [J]. STRUCTURAL CHEMISTRY, 2012, 23 (04) : 955 - 963
  • [3] A History of Cancer Chemotherapy
    DeVita, Vincent T., Jr.
    Chu, Edward
    [J]. CANCER RESEARCH, 2008, 68 (21) : 8643 - 8653
  • [4] Duan CW, 2018, J MATER CHEM A, V6, P6309, DOI [10.1039/C8TA00533H, 10.1039/c8ta00533h]
  • [5] Synergistic effect of TiF3 on the dehydriding property of α-AlH3 nano-composite
    Duan, Congwen
    Cao, Yizheng
    Hu, Lianxi
    Fu, Dong
    Ma, Jinglong
    [J]. MATERIALS LETTERS, 2019, 238 : 254 - 257
  • [6] Cd3(MoO4)(TeO3)2: A Polar 3D Compound Containing d10 - d0 SCALP-Effect Cations
    Feng, Yuquan
    Fan, Huitao
    Zhong, Zhiguo
    Wang, Hongwei
    Qiu, Dongfang
    [J]. INORGANIC CHEMISTRY, 2016, 55 (22) : 11987 - 11992
  • [7] A novel open-framework copper borophosphate containing 1-D borophosphate anion with 10-MR windows and 12-MR channels
    Feng, Yuquan
    Li, Min
    Fan, Huitao
    Huang, Qunzeng
    Qiu, Dongfang
    Shi, Hengzhen
    [J]. DALTON TRANSACTIONS, 2015, 44 (03) : 894 - 897
  • [8] Regulation of deprotonation of 3,3-di(1H-tetrazol-5-yl)pentanedioic acid: Solvothermal synthesis of La(III) and heterometallic La(III)/Cu(II) compounds for ablation of A549 cells
    Guo, Meng Yue
    Zhang, Xin
    Zhao, Liang
    Li, Yue Kang
    Chen, Dian Yu
    Yang, Gao Wen
    Li, Qiao Yun
    [J]. JOURNAL OF SOLID STATE CHEMISTRY, 2018, 259 : 104 - 109
  • [9] Platinum complexes as anticancer agents
    Kostova, Irena
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2006, 1 (01) : 1 - 22
  • [10] Copper Complexes as Anticancer Agents
    Marzano, Cristina
    Pellei, Maura
    Tisato, Francesco
    Santini, Carlo
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 185 - 211